Ssk Biosciences Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 23-10-2024
- Paid Up Capital ₹ 2.50 M
as on 23-10-2024
- Company Age 11 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.20 Cr
as on 23-10-2024
- Satisfied Charges ₹ 8.00 Cr
as on 23-10-2024
- Revenue 168.58%
(FY 2023)
- Profit 95.79%
(FY 2023)
- Ebitda 92.71%
(FY 2023)
- Net Worth 54.58%
(FY 2023)
- Total Assets 59.60%
(FY 2023)
About Ssk Biosciences
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹9.20 Cr. The company has closed loans amounting to ₹8.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Olli Sudar and Sangarappan Sivakumar serve as directors at the Company.
- CIN/LLPIN
U74900TG2013PTC090263
- Company No.
090263
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Sep 2013
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ssk Biosciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Olli Sudar  | Managing Director | 30-Sep-2013 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sangarappan Sivakumar | Director | 12-Oct-2021 | Current |
Financial Performance of Ssk Biosciences.
Ssk Biosciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 168.58% increase. The company also saw a substantial improvement in profitability, with a 95.79% increase in profit. The company's net worth Soared by an impressive increase of 54.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ssk Biosciences?
In 2023, Ssk Biosciences had a promoter holding of 99.80% and a public holding of 0.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Jun 2023 | ₹9.20 Cr | Open |
Axis Bank Limited Creation Date: 27 Jan 2023 | ₹3.00 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 20 Jan 2022 | ₹5.00 Cr | Satisfied |
How Many Employees Work at Ssk Biosciences?
Ssk Biosciences has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ssk Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ssk Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
